About Amgen
Science
Corporate Giving
Site Map
Search
Privacy & Terms
Contact Us
Patients
Medical Professionals
Partners
Investors
Careers
Media
print
mail
Home
Media
Featured Content
Update to U.S. Prescribing Information for Aranesp® and EPOGEN®
Overview
Fact Sheets
Featured Content
Press Releases
Awards & Recognition
Media Contacts
In the News
Update to U.S. Prescribing Information for Aranesp® and EPOGEN®
Amgen is committed to the highest standards of patient safety.
Amgen Announces Update to U.S. Prescribing Information for Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa)
Amgen’s Statement on Safety of Aranesp® (darbepoetin alfa) and EPOGEN® (Epoetin alfa)
UPDATED:
Letter to Healthcare Professionals
UPDATED:
Prescribing information for Aranesp® (darbepoetin alfa)
UPDATED:
Prescribing information for EPOGEN® (Epoetin alfa)
footer
